Compared to the p53 control model, the N1IC model showed significantly longer survival, ranging from 29 to 151 days post-injection (dpi) (Fig. 1B), and longer latency in tumor formation, as confirmed by weekly bioluminescence imaging (Fig. 1C). Here, TP53 is linked to neoplasm.